Class / Patent application number | Description | Number of patent applications / Date published |
514448000 | C=O bonded directly to the hetero ring (X is chalcogen) | 19 |
20080207741 | Novel Hydroxylated Aromatic Compounds - Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine | 08-28-2008 |
20080214654 | Substituted Benzyloxy-Phenylmethylamide Derivatives - The present invention relates to novel substituted benzyloxy-phenylmethylamide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1 (CMR-1) activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor oeractivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD). | 09-04-2008 |
20090054515 | SKIN-WHITENING COSMETIC - Disclosed are: a novel skin-whitening agent; and a skin-whitening cosmetic or quasi-drug which is highly effective for prevention/amelioration of melanopathy and is prepared using the skin-whitening agent. The cosmetic contains a compound represented by the general formula (I) and/or a salt thereof as an active ingredient. In the general formula (I), R | 02-26-2009 |
20090143461 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Disclosed herein are compounds having a formula: | 06-04-2009 |
20090170924 | N-Phenethylcarboxamide Derivatives - A compound of general formula (I): | 07-02-2009 |
20090275646 | THERAPEUTIC COMPOUNDS - Compounds having a structure | 11-05-2009 |
20100173981 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein. | 07-08-2010 |
20110144189 | GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING - The present invention relates to compounds having the formula: | 06-16-2011 |
20110172299 | THERAPEUTIC SUBSTITUTED CYCLOPENTANES - Disclosed herein are compounds represented by a formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed. | 07-14-2011 |
20110184055 | THERAPEUTIC AGENTS FOR TREATMENT OF OCULAR HYPERTENSION - The invention provides well-defined amides for treating glaucoma and ocular hypertension. | 07-28-2011 |
20110263692 | THERAPEUTIC COMPOUNDS - A compound having a structure | 10-27-2011 |
20120004292 | COMPOSITION FOR INJECTION COMPRISING AN INJECTION MEDICINAL PRODUCT AND A GEL - A composition of an injectable medicinal product and a gel, concentrating the medicinal product on-site to reinforce its action and/or reduce the toxicity of the medicinal product. | 01-05-2012 |
20120178798 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Disclosed herein are compounds having a formula: | 07-12-2012 |
20140187617 | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE - Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved. | 07-03-2014 |
20140323558 | THERAPEUTIC AGENTS - The invention provides well-defined compounds that are either EP | 10-30-2014 |
20140357705 | SUBSTITUTED CYCLOPENTENES AS THERAPEUTIC AGENTS - Disclosed herein are compounds having a formula: | 12-04-2014 |
20150119454 | THERAPEUTIC CYCLOPENTANOLS, COMPOSITIONS THEREOF, AND METHODS FOR USE THEREOF - Described herein are well-defined cyclopentanols useful for treating glaucoma and ocular hypertension. | 04-30-2015 |
20150322036 | REDUCED CENTRAL CORNEAL THICKENING BY USE OF HYDROPHILIC ESTER PRODRUGS OF BETA-CHLOROCYCLOPENTANES - Compositions and methods for treating glaucoma are provided. In particular hydrophilic ester prodrugs and their use to reduce central corneal thickening is provided. | 11-12-2015 |
20150336924 | AMIDOALKYLENYL AND AMIDOARYL ESTERS, COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE - The invention provides ester compounds for treating ophthalmic diseases. The esters of the invention are particularly advantageous due to their stability in aqueous solutions. | 11-26-2015 |